David Shapiro
2016
In 2016, David Shapiro earned a total compensation of $2M as Chief Medical Officer at Intercept Pharmaceuticals, a 25% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $190,000 |
|---|---|
| Option Awards | $537,908 |
| Salary | $475,000 |
| Stock Awards | $735,462 |
| Other | $29,877 |
| Total | $1,968,247 |
Shapiro received $735.5K in stock awards, accounting for 37% of the total pay in 2016.
Shapiro also received $190K in non-equity incentive plan, $537.9K in option awards, $475K in salary and $29.9K in other compensation.
Rankings
In 2016, David Shapiro's compensation ranked 4,958th out of 14,075 executives tracked by ExecPay. In other words, Shapiro earned more than 64.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,958 out of 14,075 | 65th |
Division Manufacturing | 1,772 out of 5,486 | 68th |
Major group Chemicals And Allied Products | 560 out of 1,900 | 71st |
Industry group Drugs | 416 out of 1,543 | 73rd |
Industry Pharmaceutical Preparations | 331 out of 1,173 | 72nd |
Source: SEC filing on April 27, 2018.
Shapiro's colleagues
We found two more compensation records of executives who worked with David Shapiro at Intercept Pharmaceuticals in 2016.